369 related articles for article (PubMed ID: 30424477)
1. CRISPR/Cas9 for Cancer Therapy: Hopes and Challenges.
Martinez-Lage M; Puig-Serra P; Menendez P; Torres-Ruiz R; Rodriguez-Perales S
Biomedicines; 2018 Nov; 6(4):. PubMed ID: 30424477
[TBL] [Abstract][Full Text] [Related]
2. CRISPR-Cas9, A Promising Therapeutic Tool for Cancer Therapy: A Review.
Akram F; Ikram Ul Haq ; Ahmed Z; Khan H; Ali MS
Protein Pept Lett; 2020; 27(10):931-944. PubMed ID: 32264803
[TBL] [Abstract][Full Text] [Related]
3. CRISPR-Cas9 therapeutics in cancer: promising strategies and present challenges.
Yi L; Li J
Biochim Biophys Acta; 2016 Dec; 1866(2):197-207. PubMed ID: 27641687
[TBL] [Abstract][Full Text] [Related]
4. Current Status of CRISPR/Cas9 Application in Clinical Cancer Research: Opportunities and Challenges.
Rafii S; Tashkandi E; Bukhari N; Al-Shamsi HO
Cancers (Basel); 2022 Feb; 14(4):. PubMed ID: 35205694
[TBL] [Abstract][Full Text] [Related]
5. CRISPR/Cas9 for cancer research and therapy.
Zhan T; Rindtorff N; Betge J; Ebert MP; Boutros M
Semin Cancer Biol; 2019 Apr; 55():106-119. PubMed ID: 29673923
[TBL] [Abstract][Full Text] [Related]
6. CRISPR-Cas9 as a Powerful Tool for Efficient Creation of Oncolytic Viruses.
Yuan M; Webb E; Lemoine NR; Wang Y
Viruses; 2016 Mar; 8(3):72. PubMed ID: 26959050
[TBL] [Abstract][Full Text] [Related]
7. Gene Editing in Clinical Practice: Where are We?
Mittal RD
Indian J Clin Biochem; 2019 Jan; 34(1):19-25. PubMed ID: 30728669
[TBL] [Abstract][Full Text] [Related]
8. Delivery strategies of the CRISPR-Cas9 gene-editing system for therapeutic applications.
Liu C; Zhang L; Liu H; Cheng K
J Control Release; 2017 Nov; 266():17-26. PubMed ID: 28911805
[TBL] [Abstract][Full Text] [Related]
9. The application of CRISPR-Cas9 genome editing tool in cancer immunotherapy.
Wu HY; Cao CY
Brief Funct Genomics; 2019 Mar; 18(2):129-132. PubMed ID: 29579146
[TBL] [Abstract][Full Text] [Related]
10. Genome modification by CRISPR/Cas9.
Ma Y; Zhang L; Huang X
FEBS J; 2014 Dec; 281(23):5186-93. PubMed ID: 25315507
[TBL] [Abstract][Full Text] [Related]
11. CRISPR-Cas9 for in vivo Gene Therapy: Promise and Hurdles.
Dai WJ; Zhu LY; Yan ZY; Xu Y; Wang QL; Lu XJ
Mol Ther Nucleic Acids; 2016; 5(8):e349. PubMed ID: 28131272
[TBL] [Abstract][Full Text] [Related]
12. Recent Progress in CRISPR/Cas9 Technology.
Mei Y; Wang Y; Chen H; Sun ZS; Ju XD
J Genet Genomics; 2016 Feb; 43(2):63-75. PubMed ID: 26924689
[TBL] [Abstract][Full Text] [Related]
13. CRISPR/Cas9, the Powerful New Genome-Editing Tool for Putative Therapeutics in Obesity.
Franco-Tormo MJ; Salas-Crisostomo M; Rocha NB; Budde H; Machado S; Murillo-Rodríguez E
J Mol Neurosci; 2018 May; 65(1):10-16. PubMed ID: 29732484
[TBL] [Abstract][Full Text] [Related]
14. CRISPR-Cas9 therapies in experimental mouse models of cancer.
Estêvão D; Rios Costa N; da Costa RG; Medeiros R
Future Oncol; 2018 Aug; 14(20):2083-2095. PubMed ID: 30027767
[TBL] [Abstract][Full Text] [Related]
15. Advanced In vivo Use of CRISPR/Cas9 and Anti-sense DNA Inhibition for Gene Manipulation in the Brain.
Walters BJ; Azam AB; Gillon CJ; Josselyn SA; Zovkic IB
Front Genet; 2015; 6():362. PubMed ID: 26793235
[TBL] [Abstract][Full Text] [Related]
16. The implication of CRISPR/Cas9 genome editing technology in combating human oncoviruses.
Gilani U; Shaukat M; Rasheed A; Shahid M; Tasneem F; Arshad M; Rashid N; Shahzad N
J Med Virol; 2019 Jan; 91(1):1-13. PubMed ID: 30133783
[TBL] [Abstract][Full Text] [Related]
17. Applications and advances of CRISPR-Cas9 in cancer immunotherapy.
Xia AL; He QF; Wang JC; Zhu J; Sha YQ; Sun B; Lu XJ
J Med Genet; 2019 Jan; 56(1):4-9. PubMed ID: 29970486
[TBL] [Abstract][Full Text] [Related]
18. In Vitro CRISPR/Cas9 System for Efficient Targeted DNA Editing.
Liu Y; Tao W; Wen S; Li Z; Yang A; Deng Z; Sun Y
mBio; 2015 Nov; 6(6):e01714-15. PubMed ID: 26556277
[TBL] [Abstract][Full Text] [Related]
19. Recent Advances in Genome Editing Using CRISPR/Cas9.
Ding Y; Li H; Chen LL; Xie K
Front Plant Sci; 2016; 7():703. PubMed ID: 27252719
[TBL] [Abstract][Full Text] [Related]
20. CRISPR/Cas9-Based Genome Editing for Disease Modeling and Therapy: Challenges and Opportunities for Nonviral Delivery.
Wang HX; Li M; Lee CM; Chakraborty S; Kim HW; Bao G; Leong KW
Chem Rev; 2017 Aug; 117(15):9874-9906. PubMed ID: 28640612
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
